Not applicableUnknownNCT04822090What this trial is testingParvovirus B19 Infection in Hereditary Hemolytic Anemias PatientsWho this might be right forParvovirus B19 Infection Sohag University 244
Large-scale testing (Phase 3)Study completedNCT03217422What this trial is testingADCC Mediated B-Cell dEpletion and BAFF-R BlockadeWho this might be right forAutoimmune Hepatitis Novartis Pharmaceuticals 68
Not applicableLooking for participantsNCT05484908What this trial is testingEfficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCCWho this might be right forImmune-Mediated HepatitisLiver FailureHepatocellular Carcinoma Third Affiliated Hospital, Sun Yat-Sen University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07663422What this trial is testingMycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor TherapyWho this might be right forImmune-mediated HepatitisImmune-related Adverse Event Fox Chase Cancer Center 31
Not applicableLooking for participantsNCT04476563What this trial is testingCheckpoint Inhibitor-induced Liver InjuryWho this might be right forImmune-Mediated Hepatitis University of Nottingham 160
Not applicableLooking for participantsNCT07167251What this trial is testingManagement of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose CorticosteroidsWho this might be right forImmune Related Adverse EventsImmune-Mediated HepatitisCancer University Hospital, Basel, Switzerland 63
Testing effectiveness (Phase 2)Looking for participantsNCT07378761What this trial is testingComparing UDCA and Corticosteroids in Immunotherapy Induced Cholestatic HepatitisWho this might be right forImmune-Mediated Cholestasis University Hospital, Montpellier 94
Not applicableLooking for participantsNCT06470997What this trial is testingSpecific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint InhibitorsWho this might be right forImmune-mediated Hepatitis University Hospital, Montpellier 60
Not applicableStudy completedNCT00004846What this trial is testingNucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIVWho this might be right forHepatitis CHIV Infection National Institutes of Health Clinical Center (CC) 30,000